Return to content in this issue

 

Successful adaptation of bee venom immunotherapy for a monosensitized patient to Api m 10

Ruiz-León B*1,2,5, Navas A*1,2,5, Serrano P1,2,5, Espinazo M2,5, Labrador-Horrillo M3,5, Monsalve RI4, Jurado A1,2,5, Moreno-Aguilar C1,2,5

1Department of Immunology and Allergy, Reina Sofia University Hospital, Cordoba, Spain.
2Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain.
3Allergy Section, Internal Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
4Dept.CMC R& D, ALK-Abelló, Madrid, Spain.
5National Network ARADyAL, Carlos III Health Institute, Madrid, Spain.
*Both authors contributed equally

J Investig Allergol Clin Immunol 2020; Vol. 30(4)
doi: 10.18176/jiaci.0498

Key words: Bee venom allergy, Api m 10, Venom immunotherapy effectiveness, Molecular diagnosis

Title Type Size
doi10.18176_jiaci.0498-suppl-figure.pdf pdf 139.12 Kb